{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:41:54Z","timestamp":1790786514476,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.3816\/cbc.2005.s.004","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T21:20:47Z","timestamp":1221254447000},"page":"S46-S53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"special_numbering":"S2","title":["Molecular Mechanisms of Breast Cancer Metastases to Bone"],"prefix":"10.3816","volume":"5","author":[{"given":"Theresa A.","family":"Guise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wende M.","family":"Kozlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailleen","family":"Heras-Herzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Padalecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Juan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Chirgwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2005.s.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib2","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J Biol Chem"},{"key":"10.3816\/CBC.2005.s.004_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor-bone interactions in osteolytic metastases","volume":"10","author":"Chirgwin","year":"2000","journal-title":"Crit Rev Eukaryot Gene Exp"},{"key":"10.3816\/CBC.2005.s.004_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00001433-200310000-00003","article-title":"Molecular mechanisms of cancer metastases to bone","volume":"14","author":"Chirgwin","year":"2003","journal-title":"Curr Opin Orthop"},{"key":"10.3816\/CBC.2005.s.004_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib6","first-page":"308","article-title":"Tumor-bone cellular interactions in bone metastases","volume":"4","author":"Chirgwin","year":"2004","journal-title":"J Musculoskel Neuron Interact"},{"key":"10.3816\/CBC.2005.s.004_bib7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2005.s.004_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.3816\/CBC.2005.s.004_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0092-8674(03)00468-9","article-title":"Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?","volume":"113","author":"Hynes","year":"2003","journal-title":"Cell"},{"issue":"Suppl","key":"10.3816\/CBC.2005.s.004_bib10","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/01.blo.0000093055.96273.69","article-title":"Transforming growth factor-beta in osteolytic breast cancer bone metastases","volume":"415","author":"Guise","year":"2003","journal-title":"Clin Orthop"},{"key":"10.3816\/CBC.2005.s.004_bib11","series-title":"Diseases of the Breast","first-page":"1285","article-title":"Biology of bone metastases","author":"Guise","year":"2004"},{"key":"10.3816\/CBC.2005.s.004_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/erc.0.0110207","article-title":"The role of bisphosphonates in breast and prostate cancers","volume":"11","author":"Brown","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal stem cells: nature, biology, and potential applications","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"key":"10.3816\/CBC.2005.s.004_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/bies.20052","article-title":"A new bone to pick: osteoblasts and the haematopoietic stem-cell niche","volume":"26","author":"Zhu","year":"2004","journal-title":"Bioessays"},{"key":"10.3816\/CBC.2005.s.004_bib15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1359-6446(03)02866-6","article-title":"Angiogenesis and bone repair","volume":"8","author":"Carano","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.3816\/CBC.2005.s.004_bib16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1126\/science.569363","article-title":"Chemotactic responses of tumor cells to products of resorbing bone","volume":"203","author":"Orr","year":"1978","journal-title":"Science"},{"key":"10.3816\/CBC.2005.s.004_bib17","first-page":"1399","article-title":"Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor","volume":"52","author":"Aslakson","year":"1992","journal-title":"Cancer Res"},{"issue":"3 Suppl","key":"10.3816\/CBC.2005.s.004_bib18","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/cncr.11181","article-title":"Stromal factors involved in prostate carcinoma metastasis to bone","volume":"97","author":"Cooper","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormonerelated protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"key":"10.3816\/CBC.2005.s.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(01)00798-3","article-title":"Parathyroid hormone-dependent signaling pathways regulating genes in bone cells","volume":"282","author":"Swarthout","year":"2002","journal-title":"Gene"},{"key":"10.3816\/CBC.2005.s.004_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1026578720736","article-title":"Parathyroid hormone-related protein","volume":"1","author":"Nissenson","year":"2000","journal-title":"Rev Endocr Metab Disord"},{"key":"10.3816\/CBC.2005.s.004_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2005.s.004_bib23","first-page":"2665","article-title":"Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy","volume":"24","author":"Onuma","year":"2004","journal-title":"Anticancer Res"},{"key":"10.3816\/CBC.2005.s.004_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jnci\/93.3.234","article-title":"Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases","volume":"93","author":"Henderson","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CBC.2005.s.004_bib25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1359\/jbmr.2001.16.6.1077","article-title":"Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases","volume":"16","author":"van der Pluijm","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.3816\/CBC.2005.s.004_bib26","first-page":"5571","article-title":"Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo","volume":"62","author":"Bendre","year":"2002","journal-title":"Cancer Res"},{"key":"10.3816\/CBC.2005.s.004_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jcp.10319","article-title":"Expression of connective tissue growth factor in bone: Its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo","volume":"196","author":"Safadi","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.3816\/CBC.2005.s.004_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"key":"10.3816\/CBC.2005.s.004_bib29","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2001.19.15.3562","article-title":"Biology of osteoclast activation in cancer","volume":"19","author":"Roodman","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2005.s.004_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm0995-944","article-title":"Identification of endothelin- 1 in the pathophysiology of metastatic adenocarcinoma of the prostate","volume":"1","author":"Nelson","year":"1995","journal-title":"Nat Med"},{"key":"10.3816\/CBC.2005.s.004_bib31","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1830978100","article-title":"A causal role for endothelin- 1 in the pathogenesis of osteoblastic bone metastases","volume":"100","author":"Yin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CBC.2005.s.004_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/14656566.4.6.875","article-title":"Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges","volume":"4","author":"Rosenbaum","year":"2003","journal-title":"Exp Opin Pharmacother"},{"key":"10.3816\/CBC.2005.s.004_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0305-7372(03)00071-9","article-title":"Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment","volume":"29","author":"Eaton","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"10.3816\/CBC.2005.s.004_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.0.1780169","article-title":"The CCN family: a new stimulus package","volume":"178","author":"Brigstock","year":"2003","journal-title":"J Endocrinol"},{"key":"10.3816\/CBC.2005.s.004_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1677\/erc.0.0100141","article-title":"The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives","volume":"10","author":"Menendez","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0167-0115(03)00025-9","article-title":"Adrenomedullin-a regulator of bone formation","volume":"112","author":"Cornish","year":"2003","journal-title":"Regul Pept"},{"key":"10.3816\/CBC.2005.s.004_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0167-0115(03)00037-5","article-title":"Adrenomedullin and cancer","volume":"112","author":"Zudaire","year":"2003","journal-title":"Regul Pept"},{"key":"10.3816\/CBC.2005.s.004_bib38","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1210\/en.2001-211424","article-title":"Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice","volume":"143","author":"Filvaroff","year":"2002","journal-title":"Endocrinology"},{"key":"10.3816\/CBC.2005.s.004_bib39","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(01)65919-6","article-title":"Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts","volume":"156","author":"Cramer","year":"1996","journal-title":"J Urol"},{"key":"10.3816\/CBC.2005.s.004_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/bcr302","article-title":"Prostate-specific antigen (PSA\/hK3): a further player in the field of breast cancer diagnostics?","volume":"3","author":"Mannello","year":"2001","journal-title":"Breast Cancer Res"},{"key":"10.3816\/CBC.2005.s.004_bib41","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.20056","article-title":"Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies","volume":"100","author":"Diamond","year":"2004","journal-title":"Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","article-title":"Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study","volume":"15","author":"Delmas","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2005.s.004_bib43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","article-title":"Osteopenia and osteoporosis in women with breast cancer","volume":"30","author":"Ramaswamy","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CBC.2005.s.004_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0029-7844(97)00124-5","article-title":"Predictors of bone mineral loss in patients with ovarian cancer treated with anticancer agents","volume":"90","author":"Douchi","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.3816\/CBC.2005.s.004_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women","volume":"14","author":"Powles","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2005.s.004_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-8529(02)00057-9","article-title":"Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis","volume":"32","author":"Fontana","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.3816\/CBC.2005.s.004_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00002512-200219010-00004","article-title":"Chemoprevention of breast cancer: implications for postmenopausal women","volume":"19","author":"Fabian","year":"2002","journal-title":"Drugs Aging"},{"key":"10.3816\/CBC.2005.s.004_bib48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/cncr.20388","article-title":"Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy","volume":"101","author":"Krupski","year":"2004","journal-title":"Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib49","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1210\/endo.131.5.1425428","article-title":"Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism","volume":"131","author":"Linkhart","year":"1992","journal-title":"Endocrinology"},{"key":"10.3816\/CBC.2005.s.004_bib50","doi-asserted-by":"crossref","first-page":"21352","DOI":"10.1074\/jbc.M111663200","article-title":"Proteolysis of latent transforming growth factor-beta (TGF-beta)-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix","volume":"277","author":"Dallas","year":"2002","journal-title":"J Biol Chem"},{"issue":"5 Suppl 3","key":"10.3816\/CBC.2005.s.004_bib51","first-page":"21","article-title":"The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy","volume":"18","author":"Smith","year":"2004","journal-title":"Oncology"},{"key":"10.3816\/CBC.2005.s.004_bib52","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma","volume":"94","author":"Saad","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 4","key":"10.3816\/CBC.2005.s.004_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","article-title":"Bisphosphonates: clinical experience","volume":"9","author":"Coleman","year":"2004","journal-title":"Oncologist"},{"key":"10.3816\/CBC.2005.s.004_bib54","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.20233","article-title":"IGF-1 and breast cancer: a metaanalysis","volume":"111","author":"Shi","year":"2004","journal-title":"Int J Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib55","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1073\/pnas.1633291100","article-title":"The two faces of transforming growth factor beta in carcinogenesis","volume":"100","author":"Roberts","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CBC.2005.s.004_bib56","doi-asserted-by":"crossref","first-page":"8430","DOI":"10.1073\/pnas.0932636100","article-title":"Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis","volume":"100","author":"Siegel","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CBC.2005.s.004_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF\u03b2 signaling blockade inhibits parathyroid hormone-related protein secretion by breast can cer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2005.s.004_bib58","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1073\/pnas.97.17.9373","article-title":"Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity","volume":"97","author":"Shakespeare","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CBC.2005.s.004_bib59","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/CBC.2005.s.004_bib60","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1172\/JCI0211936","article-title":"Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo","volume":"110","author":"Gallwitz","year":"2002","journal-title":"J Clin Invest"},{"key":"10.3816\/CBC.2005.s.004_bib61","doi-asserted-by":"crossref","first-page":"R608","DOI":"10.1152\/ajpregu.00538.2003","article-title":"HIFs and tumors\u2014causes and consequences","volume":"286","author":"Hopfl","year":"2004","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.3816\/CBC.2005.s.004_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jcp.10479","article-title":"HIF at the crossroads between ischemia and carcinogenesis","volume":"200","author":"Paul","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.3816\/CBC.2005.s.004_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1535-6108(03)00336-2","article-title":"Antiangiogenic therapy and tumor progression","volume":"5","author":"Blagosklonny","year":"2004","journal-title":"Cancer Cell"},{"key":"10.3816\/CBC.2005.s.004_bib64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrc1367","article-title":"Exploiting tumour hypoxia in cancer treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib65","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1158\/1535-7163.647.3.5","article-title":"Hypoxia inducible factor-1alpha as a cancer drug target","volume":"3","author":"Powis","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.3816\/CBC.2005.s.004_bib66","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CBC.2005.s.004_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1615\/CritRevEukarGeneExpr.v8.i2.10","article-title":"Interleukins in the control of osteoclast differentiation","volume":"8","author":"Martin","year":"1998","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.3816\/CBC.2005.s.004_bib68","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/en.2002-220936","article-title":"Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells","volume":"144","author":"Cornish","year":"2003","journal-title":"Endocrinology"},{"key":"10.3816\/CBC.2005.s.004_bib69","first-page":"4131","article-title":"Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells","volume":"19","author":"Nakata","year":"1999","journal-title":"Anticancer Res"},{"key":"10.3816\/CBC.2005.s.004_bib70","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bone.2003.07.012","article-title":"In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human breast cancer cells","volume":"34","author":"Rucci","year":"2004","journal-title":"Bone"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:09:56Z","timestamp":1761512996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911706930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":70,"alternative-id":["S1526820911706930"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2005.s.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Mechanisms of Breast Cancer Metastases to Bone","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2005.s.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}